Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland

Increasing Use of Disease Modifying Drugs for MS in Canada

(2014) Dalia L. Rotstein et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D

(2013) Emer Fogarty et al.   Multiple Sclerosis Journal

Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands

(2013) Korinna Karampampa et al.   JOURNAL OF MEDICAL ECONOMICS

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

(2012) Afsaneh Shirani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rehabilitation interventions in multiple sclerosis: an overview

(2012) Serafin Beer et al.   JOURNAL OF NEUROLOGY

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

(2012) Korinna Karampampa et al.   Multiple Sclerosis Journal

Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype

(2011) R. Lonergan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cost of multiple sclerosis in the Czech Republic: The COMS study

(2011) J Blahova Dusankova et al.   Multiple Sclerosis Journal

Cost-of-Illness Studies

(2011) Allison Larg et al.   PHARMACOECONOMICS

Establishing Long-Term Efficacy in Chronic Disease: Use of Recursive Partitioning and Propensity Score Adjustment to Estimate Outcome in MS

(2011) Douglas S. Goodin et al.   PLoS One

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

(2009) G Comi et al.   LANCET

Optimal recall length in survey design

(2008) Philip M. Clarke et al.   JOURNAL OF HEALTH ECONOMICS

Multiple Sclerosis in the UK

(2008) Paul McCrone et al.   PHARMACOECONOMICS